Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
Clinical trial NCT00050596 · COMPLETED
Trial details
- NCT number
- NCT00050596
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2004-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.